Core Viewpoint - Aurania Resources Ltd. plans to conduct a non-brokered private placement financing of up to 12,500,000 units at a price of C$0.12 per unit, aiming for total gross proceeds of up to C$1,500,000, with a potential increase of 25% [1][3] Financing Details - The offering consists of units that include one common share and one common share purchase warrant, with the warrant allowing the purchase of one common share at an exercise price of C$0.25 for 24 months post-closing [2] - The company may pay finders' fees of up to 7% in cash and 7% in finder warrants to eligible finders, subject to TSX Venture Exchange approval [4] Use of Proceeds - Net proceeds from the offering will primarily fund exploration programs, general working capital, and the first payment of 2025 mineral concession fees in Ecuador [3] Closing and Regulatory Approvals - The closing of the offering is expected around August 20, 2025, and is subject to necessary regulatory approvals, including TSXV approval for the listing of common shares and warrant shares [6][7] Insider Participation - Certain directors and officers are expected to acquire units under the offering, which will be treated as a related party transaction, relying on exemptions from minority shareholder approval and formal valuation requirements [8] Company Overview - Aurania is focused on mineral exploration, particularly in precious metals and copper in South America, with its flagship asset being The Lost Cities — Cutucu Project in Ecuador [10]

Funding & Strategy - Mill City Ventures III 完成 4.5 亿美元私募融资 [1] - 公司公布其 $SUI 国库策略 [1]

About Newlox Gold Ventures Corp. Newlox Gold Ventures Corp. is an emerging precious metals producer dedicated to the recovery of gold and silver from artisanal and small-scale mining operations across Latin America. The Company leverages technology to recover precious metals while remediating historical mine waste and contributing to local economic development. July 31, 2025 – TheNewswire - Vancouver, British Columbia – Newlox Gold Ventures Corp. (the "Corporation") is pleased to announce that, further to i ...

Core Points - Silver North Resources Ltd. has successfully closed its non-brokered private placement, raising a total of $370,050 from the sale of 2,467,000 HD Units at a price of $0.15 per unit [2][3] - Each HD Unit consists of one common share and one-half of a common share purchase warrant, with the warrants exercisable at $0.35 per share for a period of 48 months [2][3] - The proceeds from the HD Unit Offering will be allocated for general and administrative expenses and project pipeline development [3] Flow-Through Unit Offering Update - The flow-through unit offering has been fully subscribed, raising aggregate gross proceeds of $2,100,000 from the sale of FT Units at a price of $0.21 per unit [4] - Each FT Unit will also consist of one common share and one-half of a common share purchase warrant, with similar terms as the HD Units [4] - The FT Unit Offering is expected to close in mid-August, and certain purchasers may donate or sell their FT Units to third-party investors [4] Company Overview - Silver North Resources Ltd. owns the Haldane Silver Project, Tim Silver Project, and GDR project, with plans to acquire additional silver properties in favorable jurisdictions [6] - The company is listed on the TSX Venture Exchange under the symbol "SNAG" and trades on the OTCQB market in the United States under the symbol "TARSF" [7]

Core Points - iSpecimen Inc. has entered into a securities purchase agreement with accredited investors for approximately $1.75 million in gross proceeds [1][2] - The company plans to allocate $500,000 of the net proceeds for marketing and advertising services, with the remainder designated for working capital and general corporate purposes [1] - The offering will consist of 1,559,828 shares of common stock priced at $1.122 per share, expected to close around August 1, 2025 [2][3] Company Overview - iSpecimen operates an online marketplace connecting scientists with healthcare specimen providers for medical research [6] - The company utilizes proprietary, cloud-based technology to facilitate the search for biospecimens across a network of hospitals, labs, and other healthcare organizations [6]

Core Viewpoint - Sierra Madre Gold and Silver Ltd. has successfully closed the second tranche of its brokered private placement, raising a total of $19,500,600 from the offering [1][3]. Group 1: Offering Details - The second tranche consisted of 2,500,000 units sold at a price of $0.70 per unit, generating gross proceeds of $1,750,000 [1]. - Each unit includes one common share and one half of a common share purchase warrant, with each warrant allowing the purchase of one common share at $0.85 for 12 months [2]. - The offering was facilitated by Beacon Securities Limited as the lead agent, along with Canaccord Genuity Corp. as part of the syndicate [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to expand the capacity of the Guitarra mine, conduct exploration programs at the East District, and for working capital and general corporate purposes [3]. Group 3: Compensation and Fees - In connection with the closing of the second tranche, the company paid the agents a cash fee of $61,250 and issued 87,500 compensation options, each allowing the purchase of one common share at the issue price for 12 months [4]. Group 4: Company Overview - Sierra Madre Gold and Silver Ltd. focuses on the Guitarra mine in Mexico and the Tepic property, with the Guitarra mine being a permitted underground mine that restarted commercial production in January 2025 [7]. - The Tepic Project covers over 2,600 hectares and hosts low-sulphidation epithermal gold and silver mineralization with an existing historic resource [8].

Core Viewpoint - Group Eleven Resources Corp. has successfully closed a private placement offering, raising gross proceeds of C$5,750,000 through the issuance of 17,968,750 common shares at a price of C$0.32 per share [1] Group 1: Offering Details - The offering was completed under an underwriting agreement with Cormark Securities Inc. and Beacon Securities Limited, including the full exercise of the underwriters' option [1] - The net proceeds will be used to expand the exploration drill program at Ballywire from approximately 5,000 meters to 25,000 meters, along with working capital and general corporate purposes [2] - The common shares were sold in Canada under the listed issuer financing exemption and the accredited investor exemption, with specific hold periods applicable [3] Group 2: Underwriters and Compensation - The company paid the underwriters a cash commission of C$314,550 and issued 887,812 compensation warrants, each exercisable at C$0.32 until July 31, 2027 [4] - Glencore Canada Corporation did not exercise its participation right in the offering, maintaining a 14.1% ownership interest in the company post-offering [5] Group 3: Insider Participation - A director of the company acquired 156,250 common shares in the offering, classified as a related party transaction [6] - The company relied on exemptions from formal valuation and minority approval requirements due to the transaction's market capitalization impact [6] - The common shares issued to the insider are subject to a hold period of four months under TSX Venture Exchange policies [7] Group 4: Company Overview - Group Eleven Resources Corp. is engaged in significant mineral exploration in the Republic of Ireland, with the Ballywire discovery showcasing high grades of various minerals [9] - Ballywire is located 20 km from the company's 77.64%-owned Stonepark zinc-lead deposit, adjacent to Glencore's Pallas Green zinc-lead deposit [10]

Core Viewpoint - Millennial Potash Corp. has successfully closed a private placement, raising approximately CDN$9.19 million to fund exploration and development activities for its Banio Potash Project and for general working capital purposes [1][2][3] Group 1: Private Placement Details - The private placement consisted of 5,928,310 units priced at $1.55 each, resulting in total proceeds of CDN$9,188,880 [2] - Each unit includes one common share and one-half share purchase warrant, with warrants exercisable at CDN$2.20 per share for two years [1][2] - Commissions totaling CDN$477,846.65 were paid for non-insider units of the private placement [2] Group 2: Acquiror Information - The Quaternary Group Ltd. acquired 1,290,323 units in the private placement, increasing its total holdings to 26,092,056 common shares and 9,311,829 share purchase warrants [5][6] - Prior to the private placement, the Acquiror held approximately 24.81% of the outstanding shares on a non-diluted basis, which decreased to 24.64% post-acquisition [5][6] - The Acquiror's current holdings represent approximately 30.73% of the outstanding common shares assuming the exercise of all its share purchase warrants [6] Group 3: Use of Proceeds - Proceeds from the private placement will be allocated to exploration and development activities for the Banio Potash Project, as well as for general working capital [3]

Core Viewpoint - Osisko Development Corp. has announced a private placement offering to raise approximately US$120 million to fund the Cariboo Gold Project and general corporate purposes [1][5]. Group 1: Offering Details - The company will issue 58,560,000 units at a price of US$2.05 per unit, resulting in gross proceeds of US$120,048,000 [1]. - Each unit consists of one common share and one-half of a common share purchase warrant, with the warrants exercisable at US$2.56 for 24 months [2]. - The underwriters have an option to purchase an additional 2,440,000 units, bringing the total offering size to a maximum of US$125 million [3]. Group 2: Strategic Investor Participation - Concurrently, the company plans a non-brokered private placement of 36,600,000 units to a strategic investor for gross proceeds of US$75,030,000 [4]. - An investor rights and voting support agreement will be established with the strategic investor, allowing them to identify a director for the company board [4]. Group 3: Use of Proceeds - The net proceeds from both the offering and the non-brokered private placement will be used to fund the equity portion of the Cariboo Gold Project and for general corporate purposes [5]. - The company anticipates that these funds, along with a US$450 million project loan credit facility, will be sufficient to construct the Cariboo Gold Project [5]. Group 4: Timeline and Regulatory Approvals - The offering is expected to close around August 15, 2025, pending necessary regulatory approvals from the TSX Venture Exchange and the New York Stock Exchange [6].

Core Viewpoint - XORTX Therapeutics Inc. is conducting a non-brokered private placement to raise up to USD $114.5 million through the issuance of common share units at a price of USD $0.73 per unit, aimed at funding its gout and kidney disease treatment programs [1][3]. Group 1: Offering Details - The private placement will consist of up to 156,849 common share units, each unit comprising one common share and one common share purchase warrant [1]. - Each warrant allows the holder to purchase an additional common share at USD $1.20 for 60 months, with an acceleration clause if the share price exceeds USD $2.00 for 10 consecutive trading days [1]. - The closing date for the offering is expected around August 5, 2025, subject to necessary approvals [3]. Group 2: Use of Proceeds - Proceeds from the offering will be allocated to gout programs, general corporate purposes, and working capital [3]. Group 3: Company Overview - XORTX Therapeutics is focused on developing innovative therapies for gout and progressive kidney disease, with three advanced clinical products: XRx-026 for gout, XRx-008 for ADPKD, and XRx-101 for acute kidney injury [4]. - The company is also developing XRx-225, a pre-clinical program for Type 2 diabetic nephropathy, targeting purine metabolism and xanthine oxidase to reduce uric acid production [4].